# A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer

> clinical trial · VERIFIED · 2026-06-24

Status: RECRUITING · Sponsor: Bayer · Condition: Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

- Company: Bayer
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06661122

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.